RecruitingNCT04950218

Prevalence and Risk Factors asSOciated With CArdiac comorbiDIty in psoriAsis

PSOCADIA: Prevalence and Risk Factors asSOciated With CArdiac comorbiDIty in psoriAsis


Sponsor

Herlev and Gentofte Hospital

Enrollment

1,000 participants

Start Date

Sep 1, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

In a prospective cohort study (n = 1.000), the investigators aim to investigate the correlation between cardiac biomarkers and advanced echocardiography and determine whether these are prognostic markers of heart disease in patients suffering from psoriasis.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is looking at how common heart-related problems (like high blood pressure, heart disease, and heart rhythm issues) are among people with psoriasis, and what factors are associated with a higher risk of these problems. Psoriasis is a chronic skin condition linked to inflammation, which may also affect the heart and blood vessels. **You may be eligible if...** - You are 18 or older - You have been diagnosed with psoriasis **You may NOT be eligible if...** - You are unable to cooperate with the study requirements - You are unable to understand or sign the informed consent form Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Department of Cardiology, Herlev and Gentofte University Hospital, University of Copenhagen

Hellerup, Copenhagne, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04950218


Related Trials